NCT03817619View on ClinicalTrials.gov

Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2019

Conditions
Hepatitis CDeglutition Disorders
Interventions
DRUG

Zepatier whole tablet

Single-dose ELB/GZR as a whole tablet in a fasted state.

DRUG

Zepatier crushed tablet

Single-dose crushed ELB/GZR in a fasted state.

Trial Locations (1)

Unknown

RTCCS Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT03817619 - Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet | Biotech Hunter | Biotech Hunter